Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study

Publication | Open Access

DOI Full Paper Access

Citations

References

2023

Year

Ximena Baez‐Navarro, Mieke Van Bockstal, Diënna Nawawi, Glenn Broeckx, Cécile Colpaert, Shusma C. Doebar, M. C. H. Hogenes, Esther A. Koop, Kathleen Lambein, Dieter Peeters,

Modern Pathology

Breast OncologyOncologyHer2 ExpressionEndocrine-related CancerMedicinePathologyInterobserver VariationBreast CancerMolecular DiagnosticsRadiation OncologyTumor BiologyHer2-negative Breast Cancer